Antiglomerular basement membrane disease associated with Castleman disease

American Journal of the Medical Sciences

Volumn 337, Issue 3, 2009, Pages 206-209

  Lv, Jicheng ^a   Zhang, Hong ^a   Zhou, Fude ^a   Zou, Wanzhong ^a   Singh, Ajay K ^b   Wang, Haiyan ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Antiglomerular basement membrane antibodies; Castleman disease; Crescentic glomerulonephritis

Indexed keywords

BASEMENT MEMBRANE ANTIBODY; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 6; METHYLPREDNISOLONE; PREDNISONE; VINCRISTINE SULFATE;

ACUTE KIDNEY FAILURE; ADULT; ANEMIA; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CERVICAL LYMPHADENOPATHY; CHEMOTHERAPY; CRESCENTIC GLOMERULONEPHRITIS; DISEASE ASSOCIATION; GLOMERULONEPHRITIS; HEMATURIA; HUMAN; HUMAN TISSUE; HYPERGAMMAGLOBULINEMIA; KIDNEY BIOPSY; LYMPH NODE BIOPSY; MALE; PLASMAPHERESIS; PLEURA EFFUSION; PROTEIN BLOOD LEVEL; REMISSION; SPLENOMEGALY; THROMBOCYTOPENIA; TREATMENT OUTCOME; BLOOD; FOLLOW UP; IMMUNOLOGY; PATHOLOGY;

ADULT; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; FOLLOW-UP STUDIES; GIANT LYMPH NODE HYPERPLASIA; HUMANS; INTERLEUKIN-6; MALE;

EID: 63249121428     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e318184ce4a     Document Type: Article

References (16)

1. Castleman B, Iverson L, Menedez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 1956;9:822-830
2. Peterson BA, Frizzera G. Multicentric Castleman's disease. Semin Oncol 1993;20:636-647
3. Shahidi H, Myers JM, Kvale PA. Castleman's disease. Mayo Clin Proc 1995;70:969-977
4. Liberato NL, Bollati P, Chiofalo F, et al. Autoimmune hemolytic anemia in multicentric Castleman's disease. Haematologica 1996;81: 40-43 (Pubitemid 28020253)
5. Voorde V, Raeve D, Block D, et al. Atypical systemic lupus erythematosus or Castleman's disease. Acta Clin Belg 2004;59:161-164 (Pubitemid 39120778)
6. Marsh JH, Colbourn DS, Donovan V, et al. Castleman's disease in association with Evan's syndrome and vitiligo. Med Pediatr Oncol 1990;18:169-172 (Pubitemid 20096357)
7. Hosaka S, Kondo H. Three cases of Castleman's disease mimicking the features of collagen disease. Ryumachi 1994;34:42-47 (Pubitemid 24122736)
8. Tsukamoto Y, Hanada N, Nomura Y, et al. Rapidly progressive renal failure associated with angiofollicular lymph node hyperplasia. Am J Nephrol 1991;11:430-436
9. Furuichi K, Wada T, Shimizu M, et al. Antimyeloperoxidase-anti-body- positive rapidly progressive glomerulonephritis associated with Castleman's disease. Nephrol Dial Transplant 1998;13:1556-1558 (Pubitemid 28254339)
10. Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol 2005;129:3-17. (Pubitemid 40524047)
11. Seida A, Wada J, Morita Y, et al. Multicentric Castleman's disease associated with glomerular microangiopathy and MPGN-like lesion: does vascular endothelial cell-derived growth factor play causative or protective roles in renal injury? Am J Kidney Dis 2004;43:E3-E9.
12. Beck JT, Hsu SM, Wijdenes J, et al. Alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N Engl J Med 1994;330:602-605 (Pubitemid 24065794)
13. Nishimoto N, Sasai M, Shima Y, et al. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood 2000;95:56-61. (Pubitemid 30017224)
14. Scherokman B, Vukelja SJ, May E. Angiofollicular lymph node hyperplasia and peripheral neuropathy. Case report and literature review. Arch Intern Med 1991;151:789-790
15. Wang LC, Bu DF, Yang Y, et al. Castleman's tumours and production of autoantibody in paraneoplastic pemphigus. Lancet 2004;363:525-531 (Pubitemid 38229453)
16. Pusey CD. Anti-glomerular basement membrane disease. Kidney Int 2003;64:1535-1550